HOYA Corporation

7741.T
Medical Instruments & Supplies
2026/10/30 12:01 Updated
Market Cap: $54.9B (¥8.7T)
Stock Price: $165.12 (¥26,085)
Exchange Rate: 1 USD = ¥157.98

FY26 Q2 Earnings Presentation

Consolidated revenue grew in double digits led by the Information & Communications segment. Quarterly revenue and profit reached record highs. Growth of myopia management solutions centered on MiYOSMART is a key driver. Launch of the second-generation MiYOSMART iQ in China and international rollout are underway.

Importance:
Page Updated: October 30, 2026
IR Disclosure Date: October 30, 2026

Key Figures

  • Revenue: 2,602 hundred million yen (YoY +11% / CC +6%)
  • Profit before tax: 916 hundred million yen (YoY +27% / CC +23%)
  • Profit from ordinary activities: 894 hundred million yen (YoY +27% / CC +23%)

AI要約

Performance Overview

In FY26 Q2, consolidated revenue increased in double digits driven by the Information & Communications segment. Profit from ordinary activities remained at a high level, aided by margin improvements in the ophthalmology-related Life Care business. Quarterly revenue and profit both reached record highs. Expansion of myopia management solutions including MiYOSMART continues to be an important growth driver.

Outlook for MiYOSMART and Myopia Management

The second-generation MiYOSMART iQ will be launched beginning in winter 2025 in the China market. A 12-month clinical trial demonstrated efficacy in suppressing myopia progression, accelerating global rollout. The myopia management market has significant growth potential and is expected to reach 1 billion USD by 2030. Regional expansion and enlargement of the sales network are expected to support revenue growth.

Revenue Trend

Margin Analysis

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

HOYA Corporation

Company overview · Stock price · Financial data · All IR

View company page →